Redhill Biopharma Ltd (NASDAQ:RDHL)

14.17
Delayed Data
As of Feb 27
 +0.12 / +0.85%
Today’s Change
6.89
Today|||52-Week Range
21.00
+6.30%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Redhill Biopharma Ltd have a median target of 28.75, with a high estimate of 30.00 and a low estimate of 27.50. The median estimate represents a +102.89% increase from the last price of 14.17.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Redhill Biopharma Ltd. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.50
Sales
$0.00
Reporting Date
Apr 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 16.67%
 
 
 
 
 
 
Growthannually -63.08%
 
 
 
 
 

Sales

Growthquarterly -100.00%
 
 
 
 
 
 
Growthannually -27.86%
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account